Calendrier des promotions Alpha Tau Medical Ltd.
Calendrier avancé
Graphique simple
À propos de l'entreprise Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.Paramètres de base
IPO date
2021-03-08
ISIN
IL0011839383
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 0 | 0 |
| P/BV | 3.47 | 5 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -32.8 | 0 |
| ROE | -43.16 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.3622 | 10 |
| Debt/Ratio | 0.1454 | 10 |
| Debt/Equity | 0.3756 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 0 | 0 |
| Rentabilité Ebitda, % | 306.2 | 10 |
| Rentabilité EPS, % | 245.19 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 3.07 $ | 0 $ | 0 $ | -1.95 % | 0 % | 0 % |
| common.calendar.number_days.7d | 3.11 $ | 0 $ | 0 $ | -3.25 % | 0 % | 0 % |
| common.calendar.number_days.30d | 2.64 $ | 2.76 $ | 3.26 $ | 14.02 % | 0 % | 0 % |
| common.calendar.number_days.90d | 2.7 $ | 2.45 $ | 3.26 $ | 11.48 % | 0 % | 0 % |
| common.calendar.number_days.180d | 2.8 $ | 2.45 $ | 4.2 $ | 7.5 % | 0 % | 0 % |
| common.calendar.number_days.1y | 2.47 $ | 2.01 $ | 4.2 $ | 21.86 % | 0 % | 0 % |
| common.calendar.number_days.3y | 6.45 $ | 2.01 $ | 12.41 $ | -53.33 % | 0 % | 0 % |
| common.calendar.number_days.5y | 0 $ | 2.01 $ | 15.3 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 2.01 $ | 15.3 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 3.1 $ | 2.45 $ | 4.2 $ | -2.9 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Uzi Sofer | CEO & Chairman | 630k | 1970 (55 années) |
| Mr. Raphi Levy | Chief Financial Officer | 424k | 1985 (40 années) |
| Mr. Amnon Gat | Chief Operations Officer | 340k | 1975 (50 années) |
| Mr. Ronen Segal | Chief Technology Officer | 380k | 1973 (52 année) |
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board | 401k | 1979 (46 années) |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board | N/A | 1947 (78 années) |
| Ms. Rebecca Becker | Vice President of legal | N/A | |
| Mr. Peter M. Melnyk | Chief Commercial Officer | 376k | 1962 (63 année) |
| Prof. Itzhak Kelson | Chief Physics Officer & Member of Scientific Advisory Board | N/A | 1940 (85 années) |
| Ms. Yael Zeiger | Corporate Controller | N/A | 1983 (42 année) |
Informations sur l'entreprise
Adresse: Israel, Jerusalem, Kiryat Hamada Street 5 - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.alphatau.com
Site web: https://www.alphatau.com
